Nordic ListingsIssuer Report
AddLife AB: Quarterly Trading Report 2025 Q3
AddLife AB: Quarterly Trading Report 2025 Q3https://view.news.eu.nasdaq.com/view?id=bb51cd289770a78afa82e8947e797bce8&lang=en&src=omxlink
AddLife AB: Quarterly Trading Report 2025 Q3
Earlier from AddLife
- ALIF_B: EBITA margins exceeded 12% in both segments, with strong growth and a positive M&A outlook
- ALIF_B: Strong margin gains, robust cash flow, and new acquisition drive positive outlook
- ALIF_B: Strong sales, margin gains, and cash flow set the stage for robust growth in 2025
- ALIF_B: Stable growth, margin improvement, and strategic acquisition position AddLife for a strong Q4
- ALIF_B: Q2 2024 saw strong growth, higher profitability, and improved cash flow, supporting a positive outlook
Later from AddLife
- ALIF_B: Strong margin and profit growth, with net debt/EBITDA reduced to 2.9 and robust segment performance
- Addlife Acquires Opitek International
- ALIF_B: Profit and margin growth, strong cash flow, and lower net debt set up for accelerated M&A
- Addlife Buys Biospectrum
- AddLife´s Annual Report for 2025 is now published
Follow AddLife into a list and get an email when it puts out news.
Follow AddLife